Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7YVN | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH281 Fab | |
| 7YVN | 7YVN | Omicron BA.4/5 SARS-CoV-2 S in complex with TH281 Fab | |
| 7YVO | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH027/132 Fab | |
| 7YVO | 7YVO | Omicron BA.4/5 SARS-CoV-2 S in complex with TH027/132 Fab | |
| 7YVP | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH272/281 Fab | |
| 7YVP | 7YVP | Omicron BA.4/5 SARS-CoV-2 S in complex with TH272/281 Fab | |
| 7ZN6 | G2QFD0 | Crystal structure of laccase-like multicopper oxidase (LMCO) from Thermothelomyces thermophilus | |
| 8BON | P10104 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1 | |
| 8BON | P0DTC2 | Structure of the SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1 | |
| 8BON | 8BON | Structure of the SARS-CoV-2 spike glycoprotein in complex with the macrocyclic peptide S1B3inL1 | |
| 8DEQ | P05674 | Cryo-EM local refinement of antibody SKV09 in complex with VEEV alphavirus spike glycoprotein | |
| 8DEQ | 8DEQ | Cryo-EM local refinement of antibody SKV09 in complex with VEEV alphavirus spike glycoprotein | |
| 8DER | P05674 | Cryo-EM local refinement of antibody SKV16 in complex with VEEV alphavirus spike glycoprotein | |
| 8DER | 8DER | Cryo-EM local refinement of antibody SKV16 in complex with VEEV alphavirus spike glycoprotein | |
| 8E1G | P0DTC2 | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
| 8E1G | 8E1G | SARS-CoV-2 RBD in complex with Omicron-neutralizing antibody 2A10 | |
| 8ENT | Q9HBE4 | Interleukin-21 signaling complex with IL-21R and IL-2Rg | |
| 8ENT | Q9HBE5 | Interleukin-21 signaling complex with IL-21R and IL-2Rg | |
| 8ENT | P31785 | Interleukin-21 signaling complex with IL-21R and IL-2Rg | |
| 8FMX | 8FMX | Langya virus F glycoprotein ectodomain in prefusion form | |
| 8G5X | A0A0E2ZJY0 | Structure of the Class II Fructose-1,6-Bisphophatase from Francisella tularensis complexed with native metal cofactor Mn++ and substrate Fructose-1,6-Bisphosphate | |
| 8GOU | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH003 Fab | |
| 8GOU | 8GOU | Omicron BA.4/5 SARS-CoV-2 S in complex with TH003 Fab | |
| 8PE9 | Q08345 | Complex between DDR1 DS-like domain and PRTH-101 Fab | |
| 8PE9 | 8PE9 | Complex between DDR1 DS-like domain and PRTH-101 Fab | |
| 8SMT | 8SMT | Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain | |
| 8SMT | P0DTC2 | Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain | |
| 7FQH | Q99538 | Crystal Structure of human Legumain in complex with (2S)-N-[(3S)-5-amino-5-oxopent-1-yn-3-yl]-1-[1-[4-(cyclopropylmethoxy)phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide | |
| 7FQI | Q99538 | Crystal Structure of human Legumain in complex with (2S)-N-[(1S)-3-amino-1-cyano-3-oxopropyl]-1-[1-[4-[(2,4-difluorophenyl)methoxy]phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide | |
| 7FQJ | Q99538 | Crystal Structure of human Legumain in complex with (2S)-N-[(1S)-3-amino-1-cyano-3-oxopropyl]-1-[1-[4-[(2,4-difluorophenyl)methoxy]phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide | |
| 7FQK | Q99538 | Crystal Structure of human Legumain in complex with (2S)-N-[(3S)-5-amino-1-(1,3-oxazol-2-yl)-5-oxopent-1-yn-3-yl]-1-[1-[4-(trifluoromethoxy)phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide | |
| 7FQL | Q99538 | Crystal Structure of human Legumain in complex with (2S)-N-[(1S)-3-amino-1-cyano-3-oxopropyl]-1-[1-[4-[(2,4-difluorophenyl)methoxy]phenyl]cyclopropanecarbonyl]pyrrolidine-2-carboxamide | |
| 7ZET | P10909 | Crystal structure of human Clusterin, crystal form I | |
| 7ZEU | P10909 | Crystal structure of human Clusterin, crystal form II | |
| 8B7P | Q5AZ52 | Crystal structure of an AA9 LPMO from Aspergillus nidulans, AnLPMOC | |
| 8C9X | P36544 | human alpha7 nicotinic receptor in complex with the C4 nanobody | |
| 8C9X | 8C9X | human alpha7 nicotinic receptor in complex with the C4 nanobody | |
| 8CAU | P36544 | human alpha7 nicotinic receptor in complex with the C4 nanobody and nicotine | |
| 8CAU | 8CAU | human alpha7 nicotinic receptor in complex with the C4 nanobody and nicotine | |
| 8CC6 | P23979 | Mouse serotonin 5-HT3A receptor in complex with PZ-1922 | |
| 8CC7 | P23979 | Mouse serotonin 5-HT3A receptor in complex with PZ-1939 | |
| 8CE4 | P36544 | Human alpha7 nicotinic receptor in complex with the E3 nanobody | |
| 8CE4 | 8CE4 | Human alpha7 nicotinic receptor in complex with the E3 nanobody | |
| 8CI1 | P36544 | Human alpha7 nicotinic receptor in complex with the E3 nanobody and nicotine | |
| 8CI1 | 8CI1 | Human alpha7 nicotinic receptor in complex with the E3 nanobody and nicotine | |
| 8CI2 | P36544 | human alpha7 nicotinic receptor in complex with the C4 nanobody under sub-saturating conditions | |
| 8CI2 | 8CI2 | human alpha7 nicotinic receptor in complex with the C4 nanobody under sub-saturating conditions | |
| 8DN2 | P23415 | Cryo-EM structure of human Glycine Receptor alpha1-beta heteromer, glycine-bound state 2(expanded open) | |
| 8DN2 | P42212 | Cryo-EM structure of human Glycine Receptor alpha1-beta heteromer, glycine-bound state 2(expanded open) | |
| 8DN2 | P48167 | Cryo-EM structure of human Glycine Receptor alpha1-beta heteromer, glycine-bound state 2(expanded open) |
